Genmab – Royalties

	DARZALEX	Q/Q	Kesimpta	Q/Q
24Q2	3,731	26%	553	66%
24Q1	2,382	23%	437	64%
23Q4	3,204	11%	445	65%
23Q3	3,177	4%	449	111%
23Q2	2,952	17%	334	100%
23Q1	1,932	29%	266	106%
22Q4	2,893		270
22Q3	3,049		213
22Q2	2,523		167
22Q1	1,501		129